IL324169A - Cdk2 inhibitors and methods of using same - Google Patents
Cdk2 inhibitors and methods of using sameInfo
- Publication number
- IL324169A IL324169A IL324169A IL32416925A IL324169A IL 324169 A IL324169 A IL 324169A IL 324169 A IL324169 A IL 324169A IL 32416925 A IL32416925 A IL 32416925A IL 324169 A IL324169 A IL 324169A
- Authority
- IL
- Israel
- Prior art keywords
- heterocyclyl
- cycloalkyl
- compound
- amino
- pyrimidin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2023090329 | 2023-04-24 | ||
| US202363501034P | 2023-05-09 | 2023-05-09 | |
| CN2023127659 | 2023-10-30 | ||
| US202363615863P | 2023-12-29 | 2023-12-29 | |
| PCT/CN2024/089320 WO2024222678A1 (fr) | 2023-04-24 | 2024-04-23 | Inhibiteurs de cdk2 et leurs procédés d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324169A true IL324169A (en) | 2025-12-01 |
Family
ID=93255543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324169A IL324169A (en) | 2023-04-24 | 2025-10-23 | Cdk2 inhibitors and methods of using same |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4702015A1 (fr) |
| KR (1) | KR20260039645A (fr) |
| CN (1) | CN121443596A (fr) |
| AU (1) | AU2024259993A1 (fr) |
| IL (1) | IL324169A (fr) |
| WO (1) | WO2024222678A1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201016676A (en) * | 2008-10-03 | 2010-05-01 | Astrazeneca Ab | Heterocyclic derivatives and methods of use thereof |
| PL3060562T3 (pl) * | 2013-10-21 | 2022-01-10 | Genosco | Podstawione związki pirymidynowe i ich zastosowanie jako inhibitory syk |
| WO2018226739A1 (fr) * | 2017-06-06 | 2018-12-13 | Signalrx Pharmaceuticals, Inc. | Thiénopyranones et furanopyranones à titre d'inhibiteurs de point de contrôle et de modulateurs de l'immunité antitumorale |
| US20210101881A1 (en) * | 2018-02-12 | 2021-04-08 | Ancureall Pharmaceutical (Shanghai) Co., Ltd. | Pyrimidine compound, preparation method thereof and medical use thereof |
-
2024
- 2024-04-23 EP EP24796058.6A patent/EP4702015A1/fr active Pending
- 2024-04-23 KR KR1020257039144A patent/KR20260039645A/ko active Pending
- 2024-04-23 AU AU2024259993A patent/AU2024259993A1/en active Pending
- 2024-04-23 CN CN202480042008.6A patent/CN121443596A/zh active Pending
- 2024-04-23 WO PCT/CN2024/089320 patent/WO2024222678A1/fr not_active Ceased
-
2025
- 2025-10-23 IL IL324169A patent/IL324169A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024222678A1 (fr) | 2024-10-31 |
| CN121443596A (zh) | 2026-01-30 |
| KR20260039645A (ko) | 2026-03-20 |
| AU2024259993A1 (en) | 2025-11-06 |
| EP4702015A1 (fr) | 2026-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015335694B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| US11098010B2 (en) | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same | |
| IL310872A (en) | SOS1 inhibitor and its use | |
| JP2023126907A (ja) | Ｒｈｏ－関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用 | |
| JP7036939B2 (ja) | 癌細胞の成長抑制効果を示す新規なピリミジン誘導体及びそれを含む薬剤学的組成物 | |
| JP5974124B2 (ja) | キナーゼ阻害剤の組成物ならびに癌およびキナーゼに関連する他の疾患の治療のためのそれらの使用 | |
| CN107922431A (zh) | Hpk1抑制剂及其使用方法 | |
| JP2020525525A (ja) | Ｒｈｏ−関連プロテインキナーゼ阻害剤、ｒｈｏ−関連プロテインキナーゼ阻害剤を含む医薬組成物、当該医薬組成物の調製方法及び使用 | |
| KR102690885B1 (ko) | 금속효소 억제제 화합물 | |
| AU2016289817B2 (en) | 6-amino-quinoline-3-carbonitrils as Cot modulators | |
| EP4196228A1 (fr) | N-cyclyl-sulfonamides utiles pour inhiber raf | |
| KR20130129244A (ko) | 치환된 6,6-융합된 질소 헤테로환형 화합물 및 이의 용도 | |
| WO2015095048A1 (fr) | Analogues de sulfone cyclique et de sulfoximine et leurs utilisations | |
| CN104024246A (zh) | 作为欧若拉激酶抑制剂的取代嘧啶衍生物 | |
| CA3005918A1 (fr) | Derives d'octahydropyrrolo [3, 4-c] pyrrole et leurs utilisations | |
| JP6821680B2 (ja) | １，３，４−チアジアゾール化合物およびがんの治療におけるその使用 | |
| AU2024245104A1 (en) | Compound acting as wrn helicase inhibitor | |
| WO2021064571A1 (fr) | Dérivés de-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yle n-substitués utilisés comme inhibiteurs de la réplication du virus de l'immunodéficience humaine | |
| WO2021099832A2 (fr) | Composés antagonistes des récepteurs de l'adénosine | |
| EP3675858A2 (fr) | Composés et compositions pour l'inhibition de ire1 | |
| US20250289820A1 (en) | Non-covalent modifiers of akt1 and uses thereof | |
| JP2021523134A (ja) | グリコーゲンシンターゼキナーゼ３ベータ阻害剤としての１ｈ−インダゾール−３−カルボキサミド化合物 | |
| IL324169A (en) | Cdk2 inhibitors and methods of using same | |
| TW202023548A (zh) | 新穎噻唑衍生物以及其藥用可接受鹽類 | |
| IL324552A (en) | Novel compounds as CYP11A1 inhibitors and methods of using them |